New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences

Pharmaceutical companies offer an increasing number of inhaler devices, whether or not together with new substances, for maintenance treatment of patients with COPD or asthma. However, well-designed studies to support these developments are scarce.

Source: Respiratory Medicine CME - September 29, 2015 Category: Respiratory Medicine Authors: Vincent Ninane, Jan Vandevoorde, Didier Cataldo, E. Derom, G. Liistro, Evert Munghen, Rudi Peché, M. Schlesser, G. Verleden, Walter Vincken Source Type: research